The Effect of Deliberate Hypotension on QTc, Tp-e Intervals and Heart Rate Variability
Primary Purpose
Mandibular Prognathism, Mandibular Retrognathism
Status
Completed
Phase
Phase 4
Locations
Korea, Republic of
Study Type
Interventional
Intervention
Group R
Group N
Group D
Sponsored by
About this trial
This is an interventional prevention trial for Mandibular Prognathism focused on measuring Deliberate hypotension, QTc, Tp-e, heart rate variability
Eligibility Criteria
Inclusion Criteria:
- ASA class 1
- Adults over the age of 20
- Patients requiring deliberate hypotensive anesthesia for orthognathic surgery
Exclusion Criteria:
- Patient refusal
- Patients with arrhythmia
- Patients with cardiac anomalies or past history of cardiac surgery
- Patients with abnormal electrolyte levels
- Patients taking medications that are known to prolong QT intervals
- Patients with QTc intervals greater than 440ms
- Illiterate patients
Sites / Locations
- Young Jun Oh
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Experimental
Active Comparator
Active Comparator
Arm Label
sevoflurane-remifentanil (group R)
sevoflurane-nicardipine (group N)
sevoflurane-dexmedetomidine (group D)
Arm Description
Continuous infusion of remifentanil at 0.05 ~ 2 mcg/kg/min with sevoflurane concentration of 1 MAC
Continuous infusion of nicardipine at 1 ~ 7 mcg/kg/min with sevoflurane concentration of 1 MAC
Continuous infusion of dexmedetomidine at 0.2 ~ 1.0 mcg/kg/hr with sevoflurane concentration of 1 MAC
Outcomes
Primary Outcome Measures
Changes in QTc, Tp-e interval during deliberate hypotension
Secondary Outcome Measures
Changes in Tp-e interval during deliberate hypotension
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT01634594
Brief Title
The Effect of Deliberate Hypotension on QTc, Tp-e Intervals and Heart Rate Variability
Study Type
Interventional
2. Study Status
Record Verification Date
March 2019
Overall Recruitment Status
Completed
Study Start Date
June 2012 (undefined)
Primary Completion Date
February 2013 (Actual)
Study Completion Date
February 2013 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Yonsei University
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Deliberate hypotension is defined as lowering the systolic blood pressure to 80-90mmHg, or the mean blood pressure to 50-65mmHg. This technique is usually employed for operations that have a high risk of intraoperative hemorrhage, such as orthognathic surgery. Several different regimens are used to lower the patient's blood pressure, such as vasodilators, autonomic nervous system inhibitors, opioids and inhalation anesthetics. However, the effects that these agents have on the QTc and Tp-e intervals during deliberate hypotension is not known. Virtually every kind of anesthetic is reported to have some effect on the QTc and Tp-e intervals. Because orthognathic surgery usually takes 3-4 hours to complete, the amount of anesthetics and drugs used to maintain low blood pressure is not small. Therefore, the effect that these agents may have on the QTc and Tp-e intervals may not be negligible. The investigators of the present study found that the high dose of commonly used hypotensive agents tend to prolong these variabilities to some extent. This study will be able to provide insight as to which hypotensive anesthesia regimen has the least effect on the QTc and Tp-e intervals, and therefore will be helpful in minimizing cardiovascular risks of deliberate hypotensive anesthesia.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Mandibular Prognathism, Mandibular Retrognathism
Keywords
Deliberate hypotension, QTc, Tp-e, heart rate variability
7. Study Design
Primary Purpose
Prevention
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
66 (Actual)
8. Arms, Groups, and Interventions
Arm Title
sevoflurane-remifentanil (group R)
Arm Type
Experimental
Arm Description
Continuous infusion of remifentanil at 0.05 ~ 2 mcg/kg/min with sevoflurane concentration of 1 MAC
Arm Title
sevoflurane-nicardipine (group N)
Arm Type
Active Comparator
Arm Description
Continuous infusion of nicardipine at 1 ~ 7 mcg/kg/min with sevoflurane concentration of 1 MAC
Arm Title
sevoflurane-dexmedetomidine (group D)
Arm Type
Active Comparator
Arm Description
Continuous infusion of dexmedetomidine at 0.2 ~ 1.0 mcg/kg/hr with sevoflurane concentration of 1 MAC
Intervention Type
Drug
Intervention Name(s)
Group R
Other Intervention Name(s)
Continuous infusion of remifentanil at 0.05 ~ 2 mcg/kg/min with sevoflurane concentration of 1 MAC
Intervention Type
Drug
Intervention Name(s)
Group N
Other Intervention Name(s)
Continuous infusion of nicardipine at 1 ~ 7 mcg/kg/min with sevoflurane concentration of 1 MAC
Intervention Type
Drug
Intervention Name(s)
Group D
Other Intervention Name(s)
Continuous infustion of dexmedetomidine at 0.2 ~ 1.0 mcg/kg/hr with sevoflurane concentration of 1 MAC
Primary Outcome Measure Information:
Title
Changes in QTc, Tp-e interval during deliberate hypotension
Time Frame
Before induction of anesthesia (T1), 10 minutes after induction of anesthesia (T2), 30 minutes after target blood pressure is reached (T3), every 60 minutes after from the end of surgery
Secondary Outcome Measure Information:
Title
Changes in Tp-e interval during deliberate hypotension
Time Frame
Before induction of anesthesia (T1), 10 minutes after induction of anesthesia (T2), 30 minutes after target blood pressure is reached (T3), every 60 minutes after from the end of surgery
10. Eligibility
Sex
All
Minimum Age & Unit of Time
20 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
ASA class 1
Adults over the age of 20
Patients requiring deliberate hypotensive anesthesia for orthognathic surgery
Exclusion Criteria:
Patient refusal
Patients with arrhythmia
Patients with cardiac anomalies or past history of cardiac surgery
Patients with abnormal electrolyte levels
Patients taking medications that are known to prolong QT intervals
Patients with QTc intervals greater than 440ms
Illiterate patients
Facility Information:
Facility Name
Young Jun Oh
City
Seoul
ZIP/Postal Code
120-752
Country
Korea, Republic of
12. IPD Sharing Statement
Learn more about this trial
The Effect of Deliberate Hypotension on QTc, Tp-e Intervals and Heart Rate Variability
We'll reach out to this number within 24 hrs